- Home
- LMFA vs SNTI Comparison
LMFA vs SNTI Comparison
Compare LMFA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- SNTI
- Stock Information
- Founded
- LMFA 2008
- SNTI 2016
- Country
- LMFA United States
- SNTI United States
- Employees
- LMFA N/A
- SNTI N/A
- Industry
- LMFA Finance: Consumer Services
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- SNTI Health Care
- Exchange
- LMFA Nasdaq
- SNTI Nasdaq
- Market Cap
- LMFA 9.2M
- SNTI 10.4M
- IPO Year
- LMFA 2015
- SNTI N/A
- Fundamental
- Price
- LMFA $2.28
- SNTI $4.41
- Analyst Decision
- LMFA Hold
- SNTI Strong Buy
- Analyst Count
- LMFA 1
- SNTI 1
- Target Price
- LMFA N/A
- SNTI $12.00
- AVG Volume (30 Days)
- LMFA 149.6K
- SNTI 7.0M
- Earning Date
- LMFA 11-13-2024
- SNTI 11-14-2024
- Dividend Yield
- LMFA N/A
- SNTI N/A
- EPS Growth
- LMFA N/A
- SNTI N/A
- EPS
- LMFA N/A
- SNTI N/A
- Revenue
- LMFA $12,838,084.00
- SNTI N/A
- Revenue This Year
- LMFA N/A
- SNTI $254.47
- Revenue Next Year
- LMFA N/A
- SNTI $169.66
- P/E Ratio
- LMFA N/A
- SNTI N/A
- Revenue Growth
- LMFA 27.81
- SNTI N/A
- 52 Week Low
- LMFA $2.18
- SNTI $1.52
- 52 Week High
- LMFA $6.11
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- LMFA 34.52
- SNTI 52.77
- Support Level
- LMFA $2.67
- SNTI $4.62
- Resistance Level
- LMFA $2.90
- SNTI $5.96
- Average True Range (ATR)
- LMFA 0.25
- SNTI 1.63
- MACD
- LMFA -0.06
- SNTI -0.14
- Stochastic Oscillator
- LMFA 8.49
- SNTI 18.48
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.